Jump Nav

Our Leadership

The board of directors of PhRMA includes senior leaders representing the world’s top developers of new treatments and cures who are committed to improving health care through innovation and research. The senior executive team at PhRMA works closely with the board of directors to advance policies that ensure continued investment in biopharmaceutical innovation.

Leadership

Board of Directors

Peter Anastasiou

President, Lundbeck North America
Lundbeck LLC

-

Read More
Wolfgang Baker

Wolfgang Maximilian Baiker

President & CEO, Boehringer Ingelheim Pharmaceuticals, Inc.

-

read more
A picture of Ken Keller

Ken Keller

President and Chief Executive Officer
Daiichi Sankyo, Inc.

-

Read More

Senior Executives

Stephen J. Ubl

President and Chief Executive Officer

-

Read More

Richard Moscicki, M.D.

Chief Medical Officer and Executive Vice President of Science and Regulatory Advocacy

-

Read More

Paul Aines

Chief Financial Officer and Executive Vice President of Administration

-

Read More

Lori M. Reilly, Esq.

Chief Operating Officer 

-

read more

Robert Zirkelbach

Executive Vice President of Public Affairs 

-

Read More

James C. Stansel

Executive Vice President and General Counsel

-

Read More

Jennifer Bryant

Executive Vice President of Policy and Research

-

read more